The Mechanisms of Diameter Changes in Retinal Vessels During Hypoxia
Not Applicable
Completed
- Conditions
- Retinal Hypoxia
- Interventions
- Registration Number
- NCT02059018
- Lead Sponsor
- University of Aarhus
- Brief Summary
The primary objective is to study if a stimulation of nitric oxide and/or prostaglandin affect the diameter changes of retinal vessels during hypoxia. Diameter changes are studied using the Dynamic Vessel Analyzer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Age between >19 and <61 years
- No known systemic or ocular diseases
Exclusion Criteria
- Cardio-vascular disease
- Lung disease
- Epilepsy
- Previous ocular disease
- Previous treatment with medications influencing the intraocular pressure or the metabolism of nitric oxide or prostaglandins
- Daily intake of medicine except contraceptive pills
- Pregnancy or breastfeeding
- Known allergy against any of the drugs used in the interventions
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Normoxia COX-inhibitor + Nitroglycerin Breathing atmospheric air during recordings of diameter changes of retinal vessels. Recording are performed during normoxia alone and in combination with the associated interventions over two examination days Hypoxia COX-inhibitor Inhaling hypoxic gas mixture to induce hypoxemia during recordings of diameter changes of retinal vessels. Recording are performed during hypoxia alone and in combination with the associated interventions over two examination days Normoxia COX-inhibitor Breathing atmospheric air during recordings of diameter changes of retinal vessels. Recording are performed during normoxia alone and in combination with the associated interventions over two examination days Hypoxia COX-inhibitor + Nitroglycerin Inhaling hypoxic gas mixture to induce hypoxemia during recordings of diameter changes of retinal vessels. Recording are performed during hypoxia alone and in combination with the associated interventions over two examination days Hypoxia Nitroglycerin Inhaling hypoxic gas mixture to induce hypoxemia during recordings of diameter changes of retinal vessels. Recording are performed during hypoxia alone and in combination with the associated interventions over two examination days Normoxia Nitroglycerin Breathing atmospheric air during recordings of diameter changes of retinal vessels. Recording are performed during normoxia alone and in combination with the associated interventions over two examination days
- Primary Outcome Measures
Name Time Method Diameter changes of retinal vessels Examination day 1 and 2 Comparing the differences of diameter changes occuring during each of interventions
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms mediate retinal vessel dilation during hypoxia via nitric oxide and prostaglandin pathways?
How does COX inhibition combined with nitroglycerin compare to standard vasodilators in managing retinal hypoxia?
Which biomarkers correlate with retinal vascular response to COX inhibitors and nitrates in hypoxic conditions?
What are the potential adverse effects of combined COX inhibitor and nitroglycerin therapy in retinal hypoxia patients?
Are there alternative vasodilator combinations targeting NO and PGI2 pathways for retinal hypoxia treatment?
Trial Locations
- Locations (1)
Department of Ophtalmology, Aarhus University Hospital
🇩🇰Aarhus, Denmark
Department of Ophtalmology, Aarhus University Hospital🇩🇰Aarhus, Denmark